The GLP-1 warning-letter wave was driven heavily by unsubstantiated weight-loss claims and clinic-level promotions, not only the product itself
A.ZhangY.Trombetta-LimaM.et al
Whether you choose Sunday night, Wednesday morning, or Friday evening, sticking to that pattern ensures stable blood levels and predictable appetite suppression
The primary efficacy endpoint of ReCePI will be assessed in a mITT analysis set, including subjects who are randomized and receive study RBCs within 48 h of the end of surgery
SURMOUNT-1 (tirzepatide, 72 weeks): Discontinuation due to AEs: 4.3% (5 mg), 7.1% (10 mg), 6.2% (15 mg) vs 2.6% placebo Key characteristics: GI events occur primarily during dose escalation The GIP component does not appear to add substantial GI burden beyond GLP-1 effects Pooled SURMOUNT-1 to -4 analysis showed treatment discontinuation due to GI AEs ranged from 1.0% to 10.5% Retatrutide# Retatrutide adds glucagon receptor agonism to GLP-1 and GIP, creating a triple agonist
If you have asthma or other health considerations, the best approach is often "low and slow." Step 1: Consult Your Doctor
